The House resumed from May 12 consideration of the motion in relation to the amendments made by the Senate to Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts, and of the amendment.
In the House of Commons on May 15th, 2017. See this statement in context.